GUANFACINE HYDROCHLORIDE

GUANFACINE HYDROCHLORIDE was reported 4719 times

These side effects are most commonly reported by patients taking GUANFACINE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 579
1 OFF LABEL USE 402
2 AGGRESSION 230
3 SOMNOLENCE 229
4 FATIGUE 220
5 TOXICITY TO VARIOUS AGENTS 207
6 HYPOTENSION 189
7 NAUSEA 186
8 INSOMNIA 180
9 ANXIETY 179
10 INTENTIONAL OVERDOSE 174
11 HEADACHE 167
12 DRUG INTERACTION 166
13 DIZZINESS 158
14 AGITATION 154
15 BRADYCARDIA 145
16 VOMITING 143
17 CONDITION AGGRAVATED 142
18 PRODUCT DOSE OMISSION ISSUE 135
19 WEIGHT INCREASED 133
20 IRRITABILITY 118
21 PRODUCT USE IN UNAPPROVED INDICATION 115
22 DIARRHOEA 112
23 OVERDOSE 111
24 DEPRESSION 110
25 PRODUCT SUBSTITUTION ISSUE 107
26 ABNORMAL BEHAVIOUR 106
27 DECREASED APPETITE 105
28 HYPERTENSION 104
29 SEIZURE 101
30 SUICIDAL IDEATION 100
31 RASH 97
32 TREATMENT FAILURE 94
33 PRODUCT USE ISSUE 88
34 ELECTROCARDIOGRAM QT PROLONGED 87
35 CONSTIPATION 85
36 ANGER 82
37 WEIGHT DECREASED 80
38 PRODUCT QUALITY ISSUE 79
39 PRURITUS 79
40 LETHARGY 78
41 FALL 76
42 PAIN 76
43 TACHYCARDIA 72
44 ABDOMINAL PAIN UPPER 70
45 SUICIDE ATTEMPT 70
46 COMPLETED SUICIDE 69
47 PSYCHOMOTOR HYPERACTIVITY 69
48 DYSPNOEA 68
49 SEDATION 66
50 MALAISE 65
51 HYPERHIDROSIS 64
52 ASTHENIA 62
53 FEELING ABNORMAL 60
54 INJECTION SITE PAIN 60
55 TREMOR 60
56 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60
57 DISTURBANCE IN ATTENTION 59
58 SEROTONIN SYNDROME 59
59 COUGH 58
60 SINUS BRADYCARDIA 58
61 NO ADVERSE EVENT 57
62 PNEUMONIA 55
63 INCORRECT DOSE ADMINISTERED 52
64 INTENTIONAL SELF-INJURY 52
65 PYREXIA 51
66 TIC 51
67 HALLUCINATION 50
68 EMOTIONAL DISORDER 49
69 ABDOMINAL PAIN 48
70 COMA 48
71 DYSTONIA 48
72 HOSPITALISATION 48
73 HYPERSENSITIVITY 48
74 LOSS OF CONSCIOUSNESS 48
75 SLEEP DISORDER 48
76 ARTHRALGIA 47
77 BLOOD PRESSURE INCREASED 46
78 PARAESTHESIA 46
79 COVID-19 45
80 BEHAVIOUR DISORDER 44
81 DRUG DOSE OMISSION BY DEVICE 44
82 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44
83 NASOPHARYNGITIS 44
84 PAIN IN EXTREMITY 44
85 ABDOMINAL DISCOMFORT 43
86 GASTROINTESTINAL DISORDER 43
87 INFLUENZA 43
88 DEATH 42
89 DRY MOUTH 41
90 ILLNESS 41
91 RESTLESSNESS 41
92 DRUG INTOLERANCE 40
93 IMPULSIVE BEHAVIOUR 40
94 MOOD SWINGS 40
95 WITHDRAWAL SYNDROME 40
96 DEPRESSED LEVEL OF CONSCIOUSNESS 39
97 CHEST PAIN 38
98 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38
99 DYSARTHRIA 38
100 MIGRAINE 38
101 DEPRESSED MOOD 37
102 CARDIAC ARREST 36
103 HEART RATE INCREASED 36
104 MENTAL DISORDER 36
105 BLOOD PRESSURE DECREASED 35
106 DEHYDRATION 35
107 DERMATITIS ATOPIC 35
108 PERIPHERAL SWELLING 35
109 SYNCOPE 35
110 COGNITIVE DISORDER 34
111 EMOTIONAL DISTRESS 34
112 ASTHMA 33
113 CONFUSIONAL STATE 33
114 FLUSHING 33
115 GAIT DISTURBANCE 33
116 MUSCLE SPASMS 33
117 ORTHOSTATIC HYPOTENSION 33
118 PALPITATIONS 33
119 RENAL FAILURE 33
120 URTICARIA 33
121 ATTENTION DEFICIT HYPERACTIVITY DISORDER 32
122 DEVICE ISSUE 32
123 TREATMENT NONCOMPLIANCE 32
124 CHRONIC KIDNEY DISEASE 31
125 DRY SKIN 31
126 URINARY TRACT INFECTION 31
127 BLOOD GLUCOSE INCREASED 30
128 MANIA 30
129 PULMONARY OEDEMA 30
130 ACUTE KIDNEY INJURY 29
131 BACK PAIN 29
132 ADVERSE DRUG REACTION 28
133 DRUG HYPERSENSITIVITY 28
134 DYSKINESIA 28
135 SINUSITIS 28
136 VISION BLURRED 28
137 BRADYPNOEA 27
138 DEVICE BREAKAGE 27
139 DISCOMFORT 27
140 GYNAECOMASTIA 27
141 INTENTIONAL DOSE OMISSION 27
142 DEVICE LEAKAGE 26
143 ERYTHEMA 26
144 PRESYNCOPE 26
145 PRODUCT ADMINISTRATION INTERRUPTED 26
146 PRODUCT DISPENSING ERROR 26
147 PRODUCT DOSE OMISSION 26
148 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26
149 THERAPY NON-RESPONDER 26
150 ACCIDENTAL OVERDOSE 25
151 AFFECTIVE DISORDER 25
152 CRYING 25
153 DRUG DOSE OMISSION 25
154 INCREASED APPETITE 25
155 OEDEMA PERIPHERAL 25
156 DRUG EFFECT DECREASED 24
157 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24
158 NEUROLEPTIC MALIGNANT SYNDROME 24
159 THERAPY PARTIAL RESPONDER 24
160 GASTROINTESTINAL HAEMORRHAGE 23
161 GENERALISED TONIC-CLONIC SEIZURE 23
162 INFECTION 23
163 INTENTIONAL PRODUCT USE ISSUE 23
164 MOOD ALTERED 23
165 RESPIRATORY DEPRESSION 23
166 THERAPY CESSATION 23
167 ABDOMINAL DISTENSION 22
168 ADVERSE EVENT 22
169 CATATONIA 22
170 CHOROIDAL EFFUSION 22
171 HYPERSOMNIA 22
172 THERAPEUTIC PRODUCT EFFECT DECREASED 22
173 THERAPEUTIC RESPONSE DECREASED 22
174 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 21
175 DELIRIUM 21
176 DEVICE MECHANICAL ISSUE 21
177 HALLUCINATION, AUDITORY 21
178 INTENTIONAL PRODUCT MISUSE 21
179 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21
180 AMNESIA 20
181 DISTRIBUTIVE SHOCK 20
182 MEMORY IMPAIRMENT 20
183 PRODUCT ADHESION ISSUE 20
184 SPEECH DISORDER 20
185 STRESS 20
186 STRESS CARDIOMYOPATHY 20
187 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 19
188 CHILLS 19
189 CONTUSION 19
190 DYSPHAGIA 19
191 ECZEMA 19
192 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 19
193 ENCEPHALOPATHY 19
194 GASTROOESOPHAGEAL REFLUX DISEASE 19
195 NEPHROGENIC DIABETES INSIPIDUS 19
196 OBSESSIVE-COMPULSIVE DISORDER 19
197 PRODUCT AVAILABILITY ISSUE 19
198 THERAPY CHANGE 19
199 THERAPY INTERRUPTED 19
200 URINARY RETENTION 19
201 AFFECT LABILITY 18
202 BRONCHITIS 18
203 DIABETIC KETOACIDOSIS 18
204 DRUG TOLERANCE 18
205 FRUSTRATION TOLERANCE DECREASED 18
206 MACULAR DETACHMENT 18
207 NASAL CONGESTION 18
208 NIGHTMARE 18
209 OROPHARYNGEAL PAIN 18
210 PRODUCT PHYSICAL ISSUE 18
211 SWELLING 18
212 UNRESPONSIVE TO STIMULI 18
213 ACCIDENTAL EXPOSURE TO PRODUCT 17
214 CEREBRAL DISORDER 17
215 EAR INFECTION 17
216 HEART RATE DECREASED 17
217 LACTIC ACIDOSIS 17
218 MENTAL STATUS CHANGES 17
219 MOVEMENT DISORDER 17
220 RESPIRATORY FAILURE 17
221 SCREAMING 17
222 SELF-DESTRUCTIVE BEHAVIOUR 17
223 SINUS TACHYCARDIA 17
224 SWELLING FACE 17
225 UNDERDOSE 17
226 UNEVALUABLE EVENT 17
227 WHITE BLOOD CELL COUNT DECREASED 17
228 ALOPECIA 16
229 AUTISM SPECTRUM DISORDER 16
230 BLOOD CREATINE PHOSPHOKINASE INCREASED 16
231 CARDIAC FAILURE 16
232 CHEST DISCOMFORT 16
233 DRUG LEVEL INCREASED 16
234 DRUG WITHDRAWAL SYNDROME 16
235 EATING DISORDER 16
236 ENURESIS 16
237 EPISTAXIS 16
238 INJECTION SITE SWELLING 16
239 MUSCULAR WEAKNESS 16
240 NEPHROLITHIASIS 16
241 OPPOSITIONAL DEFIANT DISORDER 16
242 POOR QUALITY SLEEP 16
243 PSYCHOTIC DISORDER 16
244 RECALLED PRODUCT ADMINISTERED 16
245 RHINORRHOEA 16
246 SKIN EXFOLIATION 16
247 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 16
248 ANAEMIA 15
249 APPLICATION SITE ERYTHEMA 15
250 BIPOLAR DISORDER 15
251 DYSPEPSIA 15
252 HYPERAMMONAEMIA 15
253 IMPAIRED QUALITY OF LIFE 15
254 INJECTION SITE ERYTHEMA 15
255 MIDDLE INSOMNIA 15
256 PARANOIA 15
257 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15
258 PRIAPISM 15
259 PSORIASIS 15
260 SINUS ARREST 15
261 SKIN FISSURES 15
262 SURGERY 15
263 THERAPEUTIC RESPONSE SHORTENED 15
264 URINARY INCONTINENCE 15
265 AKATHISIA 14
266 ALTERED STATE OF CONSCIOUSNESS 14
267 ARRHYTHMIA 14
268 BLINDNESS UNILATERAL 14
269 BRAIN FOG 14
270 CATARACT 14
271 DEVICE USE ERROR 14
272 DIPLOPIA 14
273 DISTRACTIBILITY 14
274 DROOLING 14
275 EYE PAIN 14
276 FLUID RETENTION 14
277 HALLUCINATION, VISUAL 14
278 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14
279 MYALGIA 14
280 MYDRIASIS 14
281 NEPHROGENIC ANAEMIA 14
282 NEUTROPENIA 14
283 TARDIVE DYSKINESIA 14
284 THERAPEUTIC RESPONSE UNEXPECTED 14
285 THIRST 14
286 ACNE 13
287 APATHY 13
288 BALANCE DISORDER 13
289 CEREBROVASCULAR ACCIDENT 13
290 DISORIENTATION 13
291 EDUCATIONAL PROBLEM 13
292 EYE IRRITATION 13
293 FEELING HOT 13
294 HYPOAESTHESIA 13
295 HYPOXIA 13
296 INJECTION SITE REACTION 13
297 MENTAL IMPAIRMENT 13
298 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13
299 MUSCLE RIGIDITY 13
300 NERVOUS SYSTEM DISORDER 13
301 PRESCRIBED OVERDOSE 13
302 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13
303 RASH PRURITIC 13
304 REBOUND EFFECT 13
305 SEDATION COMPLICATION 13
306 SELF-INJURIOUS IDEATION 13
307 VERTIGO 13
308 VIRAL INFECTION 13
309 VISUAL IMPAIRMENT 13
310 ANTICHOLINERGIC SYNDROME 12
311 ARTHRITIS 12
312 BLOOD TRIGLYCERIDES INCREASED 12
313 CONVULSION 12
314 DEFIANT BEHAVIOUR 12
315 DEVICE DIFFICULT TO USE 12
316 DYSPHONIA 12
317 END STAGE RENAL DISEASE 12
318 EXTRA DOSE ADMINISTERED 12
319 FEAR 12
320 FLATULENCE 12
321 GASTROENTERITIS VIRAL 12
322 GENERAL PHYSICAL HEALTH DETERIORATION 12
323 INFLAMMATION 12
324 INITIAL INSOMNIA 12
325 INSURANCE ISSUE 12
326 MYOCARDIAL INFARCTION 12
327 NEUROPATHY PERIPHERAL 12
328 OBESITY 12
329 OEDEMA 12
330 OROMANDIBULAR DYSTONIA 12
331 PANIC ATTACK 12
332 POOR QUALITY DEVICE USED 12
333 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 12
334 PRODUCT DOSE OMISSION IN ERROR 12
335 RASH ERYTHEMATOUS 12
336 RETCHING 12
337 RHABDOMYOLYSIS 12
338 SEPSIS 12
339 SKIN HAEMORRHAGE 12
340 THINKING ABNORMAL 12
341 APPLICATION SITE PRURITUS 11
342 BRAIN OEDEMA 11
343 BRUGADA SYNDROME 11
344 CARDIAC DISORDER 11
345 CARDIAC FAILURE ACUTE 11
346 CROHN^S DISEASE 11
347 DISSOCIATION 11
348 DRUG DEPENDENCE 11
349 DRUG LEVEL ABOVE THERAPEUTIC 11
350 DRY EYE 11
351 ELECTROCARDIOGRAM T WAVE ABNORMAL 11
352 EXTRAPYRAMIDAL DISORDER 11
353 EYE SWELLING 11
354 HEAD INJURY 11
355 HYPERTENSIVE URGENCY 11
356 HYPOPHAGIA 11
357 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11
358 INFLUENZA LIKE ILLNESS 11
359 MUSCLE TWITCHING 11
360 NIGHT SWEATS 11
361 OCULAR HYPERAEMIA 11
362 OXYGEN SATURATION DECREASED 11
363 PALLOR 11
364 PRODUCT ADMINISTRATION ERROR 11
365 PRODUCT PREPARATION ISSUE 11
366 PRODUCT USE COMPLAINT 11
367 RENAL DISORDER 11
368 SALIVARY HYPERSECRETION 11
369 SUSPECTED SUICIDE 11
370 VASOPLEGIA SYNDROME 11
371 DERMATITIS CONTACT 10
372 DEVICE MALFUNCTION 10
373 DIABETES MELLITUS 10
374 DRUG EFFECT LESS THAN EXPECTED 10
375 DRUG PRESCRIBING ERROR 10
376 EOSINOPHILIC OESOPHAGITIS 10
377 FUNGAL INFECTION 10
378 HEPATIC ENZYME INCREASED 10
379 HERPES ZOSTER 10
380 HORNER^S SYNDROME 10
381 IMPAIRED GASTRIC EMPTYING 10
382 INABILITY TO AFFORD MEDICATION 10
383 INFUSION SITE ERYTHEMA 10
384 MEDICATION ERROR 10
385 MIOSIS 10
386 MOBILITY DECREASED 10
387 NERVOUSNESS 10
388 PRODUCT PRESCRIBING ISSUE 10
389 PRODUCT TASTE ABNORMAL 10
390 PULSELESS ELECTRICAL ACTIVITY 10
391 RENAL IMPAIRMENT 10
392 RENAL INJURY 10
393 SEROUS RETINAL DETACHMENT 10
394 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10
395 STATUS EPILEPTICUS 10
396 TROPONIN INCREASED 10
397 UPPER RESPIRATORY TRACT INFECTION 10
398 ANHEDONIA 9
399 DELUSION 9
400 DISEASE PROGRESSION 9
401 DISTURBANCE IN SOCIAL BEHAVIOUR 9
402 DYSPHEMIA 9
403 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9
404 GAIT INABILITY 9
405 HOMICIDAL IDEATION 9
406 HYPERGLYCAEMIA 9
407 HYPERTENSIVE EMERGENCY 9
408 HYPOPROTEINAEMIA 9
409 ILL-DEFINED DISORDER 9
410 IMMUNE THROMBOCYTOPENIC PURPURA 9
411 INSULIN RESISTANCE 9
412 LEUKOCYTOSIS 9
413 MYOSITIS 9
414 PHARYNGITIS STREPTOCOCCAL 9
415 PLEURAL EFFUSION 9
416 PRE-EXISTING CONDITION IMPROVED 9
417 PRODUCT STORAGE ERROR 9
418 RASH MACULAR 9
419 SENSORY DISTURBANCE 9
420 SHOCK 9
421 SUBRETINAL FLUID 9
422 THERAPEUTIC RESPONSE CHANGED 9
423 TOURETTE^S DISORDER 9
424 ASPIRATION 8
425 ATAXIA 8
426 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8
427 BLISTER 8
428 BLOOD CHOLESTEROL INCREASED 8
429 BLOOD GLUCOSE DECREASED 8
430 BLOOD LACTATE DEHYDROGENASE INCREASED 8
431 BODY MASS INDEX DECREASED 8
432 CARDIOGENIC SHOCK 8
433 DIZZINESS POSTURAL 8
434 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8
435 DRUG EFFECT INCOMPLETE 8
436 DRUG RESISTANCE 8
437 DYSGEUSIA 8
438 DYSPHORIA 8
439 EUPHORIC MOOD 8
440 FEELING COLD 8
441 FEELING JITTERY 8
442 INCORRECT DOSE ADMINISTERED BY DEVICE 8
443 INCORRECT DRUG ADMINISTRATION DURATION 8
444 INFUSION SITE PAIN 8
445 INJECTION SITE MASS 8
446 INJURY 8
447 LIP SWELLING 8
448 LOGORRHOEA 8
449 MEDICATION RESIDUE PRESENT 8
450 MOUTH ULCERATION 8
451 NECK PAIN 8
452 PAIN OF SKIN 8
453 PARKINSONISM 8
454 POLLAKIURIA 8
455 POST-TRAUMATIC STRESS DISORDER 8
456 PULMONARY EMBOLISM 8
457 RESPIRATORY ARREST 8
458 RIB FRACTURE 8
459 SEXUAL DYSFUNCTION 8
460 SKIN DISCOLOURATION 8
461 STAPHYLOCOCCAL INFECTION 8
462 STARING 8
463 TINNITUS 8
464 UPPER AIRWAY OBSTRUCTION 8
465 WRONG PRODUCT ADMINISTERED 8
466 ABNORMAL WEIGHT GAIN 7
467 ACUTE RESPIRATORY DISTRESS SYNDROME 7
468 ALANINE AMINOTRANSFERASE INCREASED 7
469 ANAPHYLACTIC REACTION 7
470 ANAPHYLACTIC SHOCK 7
471 ANION GAP 7
472 APHASIA 7
473 APPLICATION SITE IRRITATION 7
474 ARTHROPATHY 7
475 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7
476 BRUXISM 7
477 BUNDLE BRANCH BLOCK RIGHT 7
478 BURNING SENSATION 7
479 CARDIAC DYSFUNCTION 7
480 CARDIAC FAILURE CONGESTIVE 7
481 CARDIO-RESPIRATORY ARREST 7
482 CARDIOTOXICITY 7
483 CHOLELITHIASIS 7
484 CYSTITIS 7
485 DERMATILLOMANIA 7
486 DEVICE DELIVERY SYSTEM ISSUE 7
487 DEVICE INFORMATION OUTPUT ISSUE 7
488 DISEASE RECURRENCE 7
489 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7
490 EYE DISORDER 7
491 EYE PRURITUS 7
492 GLYCOSYLATED HAEMOGLOBIN INCREASED 7
493 GRANDIOSITY 7
494 GRIMACING 7
495 HAEMORRHAGE 7
496 HOSTILITY 7
497 HUNGER 7
498 INHIBITORY DRUG INTERACTION 7
499 INJECTION SITE PRURITUS 7
500 LIMB DISCOMFORT 7
501 LOWER LIMB FRACTURE 7
502 MUSCULOSKELETAL STIFFNESS 7
503 NEUROTOXICITY 7
504 PARALYSIS 7
505 PARKINSON^S DISEASE 7
506 PHYSICAL ASSAULT 7
507 PRODUCT DISTRIBUTION ISSUE 7
508 RESTLESS LEGS SYNDROME 7
509 SLEEP TERROR 7
510 SOMNAMBULISM 7
511 STOMATITIS 7
512 TACHYPHRENIA 7
513 TRANSCRIPTION MEDICATION ERROR 7
514 TRISMUS 7
515 VENTRICULAR FIBRILLATION 7
516 WHITE BLOOD CELL COUNT INCREASED 7
517 ACTIVITIES OF DAILY LIVING IMPAIRED 6
518 APNOEA 6
519 APPETITE DISORDER 6
520 APPLICATION SITE PAIN 6
521 APPLICATION SITE RASH 6
522 ASPARTATE AMINOTRANSFERASE INCREASED 6
523 BLOOD POTASSIUM DECREASED 6
524 CHOROIDAL DETACHMENT 6
525 CIRCULATORY COLLAPSE 6
526 CLOSTRIDIUM DIFFICILE INFECTION 6
527 CRANIOCEREBRAL INJURY 6
528 CYSTIC FIBROSIS 6
529 DECREASED ACTIVITY 6
530 DEVICE ADHESION ISSUE 6
531 DEVICE DISLOCATION 6
532 DEVICE PHYSICAL PROPERTY ISSUE 6
533 DRUG ABUSE 6
534 DRUG ADMINISTRATION ERROR 6
535 DRUG-GENETIC INTERACTION 6
536 EAR PAIN 6
537 EPILEPSY 6
538 EXCESSIVE EYE BLINKING 6
539 FEEDING DISORDER 6
540 FORCED EXPIRATORY VOLUME ABNORMAL 6
541 FORMICATION 6
542 GLOMERULAR FILTRATION RATE DECREASED 6
543 HAEMATOCHEZIA 6
544 HAEMOGLOBIN DECREASED 6
545 HYPERPHAGIA 6
546 HYPOGLYCAEMIA 6
547 HYPOTHERMIA 6
548 IMPAIRED HEALING 6
549 IMPULSE-CONTROL DISORDER 6
550 INCONTINENCE 6
551 INCORRECT PRODUCT ADMINISTRATION DURATION 6
552 INJECTION SITE BRUISING 6
553 INJECTION SITE HAEMORRHAGE 6
554 INJECTION SITE URTICARIA 6
555 JOINT SWELLING 6
556 LIMB INJURY 6
557 LIQUID PRODUCT PHYSICAL ISSUE 6
558 LIVER FUNCTION TEST ABNORMAL 6
559 LUNG DISORDER 6
560 NEGATIVISM 6
561 NEURALGIA 6
562 PLATELET COUNT DECREASED 6
563 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6
564 PRODUCT COMPLAINT 6
565 PRODUCT FORMULATION ISSUE 6
566 PRODUCT SUPPLY ISSUE 6
567 RENAL FAILURE ACUTE 6
568 SENSITIVITY TO WEATHER CHANGE 6
569 SEPTIC SHOCK 6
570 SKIN BURNING SENSATION 6
571 SLEEP APNOEA SYNDROME 6
572 SLEEP DEFICIT 6
573 SLUGGISHNESS 6
574 SUICIDAL BEHAVIOUR 6
575 SUPRAVENTRICULAR EXTRASYSTOLES 6
576 TRANSIENT ISCHAEMIC ATTACK 6
577 TRICHOTILLOMANIA 6
578 TYPE 2 DIABETES MELLITUS 6
579 ACTIVATION SYNDROME 5
580 ANGIOEDEMA 5
581 ATRIAL FIBRILLATION 5
582 ATRIOVENTRICULAR BLOCK 5
583 ATRIOVENTRICULAR BLOCK COMPLETE 5
584 BIPOLAR I DISORDER 5
585 BLINDNESS 5
586 BLOOD PROLACTIN INCREASED 5
587 BLOOD SODIUM DECREASED 5
588 BLOOD UREA INCREASED 5
589 BLOOD URIC ACID INCREASED 5
590 CARDIAC ANEURYSM 5
591 CELLULITIS 5
592 CHOKING 5
593 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5
594 COLD SWEAT 5
595 COMPLICATION ASSOCIATED WITH DEVICE 5
596 COORDINATION ABNORMAL 5
597 CYANOSIS 5
598 DEAFNESS 5
599 DEEP VEIN THROMBOSIS 5
600 DEVICE DEFECTIVE 5
601 DISABILITY 5
602 DISINHIBITION 5
603 DISRUPTIVE MOOD DYSREGULATION DISORDER 5
604 DRUG DISPENSING ERROR 5
605 DRUG EFFECT VARIABLE 5
606 DRUG LEVEL DECREASED 5
607 DYSPNOEA EXERTIONAL 5
608 DYSURIA 5
609 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 5
610 GRANULOCYTOPENIA 5
611 HAIR GROWTH ABNORMAL 5
612 HOT FLUSH 5
613 HYPERPROLACTINAEMIA 5
614 HYPERTONIC BLADDER 5
615 HYPOMANIA 5
616 HYPONATRAEMIA 5
617 HYSTERECTOMY 5
618 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5
619 IMPAIRED WORK ABILITY 5
620 INFUSION SITE DISCHARGE 5
621 INFUSION SITE HAEMORRHAGE 5
622 INFUSION SITE REACTION 5
623 INTESTINAL OBSTRUCTION 5
624 JOINT INJURY 5
625 LEFT VENTRICULAR HYPERTROPHY 5
626 LOCALISED INFECTION 5
627 MAJOR DEPRESSION 5
628 MENSTRUAL DISORDER 5
629 METABOLIC ACIDOSIS 5
630 NEEDLE ISSUE 5
631 OBSTRUCTIVE AIRWAYS DISORDER 5
632 ORAL PAIN 5
633 OSTEOARTHRITIS 5
634 PAIN IN JAW 5
635 PETIT MAL EPILEPSY 5
636 PHOTOPHOBIA 5
637 POOR VENOUS ACCESS 5
638 PRESCRIBED UNDERDOSE 5
639 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5
640 PROCEDURAL PAIN 5
641 PRODUCT PRESCRIBING ERROR 5
642 PRODUCTIVE COUGH 5
643 REACTION TO EXCIPIENT 5
644 REBOUND ACID HYPERSECRETION 5
645 RECTAL HAEMORRHAGE 5
646 RESPIRATORY ACIDOSIS 5
647 RESTLESS LEG AUGMENTATION SYNDROME 5
648 RHINOVIRUS INFECTION 5
649 ROAD TRAFFIC ACCIDENT 5
650 SCAR 5
651 SCRATCH 5
652 SEASONAL ALLERGY 5
653 SELECTIVE MUTISM 5
654 SNORING 5
655 SOCIAL ANXIETY DISORDER 5
656 STREPTOCOCCAL INFECTION 5
657 SWOLLEN TONGUE 5
658 TEMPERATURE INTOLERANCE 5
659 THERAPEUTIC PRODUCT INEFFECTIVE 5
660 THROMBOCYTOPENIA 5
661 TORTICOLLIS 5
662 TRANSAMINASES INCREASED 5
663 TRANSPLANT REJECTION 5
664 TROPONIN I INCREASED 5
665 UPPER LIMB FRACTURE 5
666 VENTRICULAR TACHYCARDIA 5
667 WEIGHT GAIN POOR 5
668 WHEEZING 5
669 ABASIA 4
670 ABNORMAL DREAMS 4
671 ABNORMAL LOSS OF WEIGHT 4
672 ACUTE RESPIRATORY FAILURE 4
673 AGEUSIA 4
674 AMENORRHOEA 4
675 ANAL INCONTINENCE 4
676 ANTICHOLINERGIC EFFECT 4
677 AREFLEXIA 4
678 ARTERIOSPASM CORONARY 4
679 ARTHROPOD BITE 4
680 ATRIOVENTRICULAR DISSOCIATION 4
681 BACK DISORDER 4
682 BLEPHAROSPASM 4
683 BLOOD LACTIC ACID INCREASED 4
684 BLOOD POTASSIUM INCREASED 4
685 BLOOD PRESSURE FLUCTUATION 4
686 BRAIN INJURY 4
687 CARDIOMEGALY 4
688 CARPAL TUNNEL SYNDROME 4
689 CATHETER SITE INFECTION 4
690 CHANGE IN SEIZURE PRESENTATION 4
691 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4
692 COELIAC DISEASE 4
693 CONCUSSION 4
694 DARK CIRCLES UNDER EYES 4
695 DIABETES MELLITUS INADEQUATE CONTROL 4
696 DRUG DELIVERY SYSTEM ISSUE 4
697 DRUG TOLERANCE DECREASED 4
698 DRUG WITHDRAWAL SYNDROME NEONATAL 4
699 DYSSTASIA 4
700 ECONOMIC PROBLEM 4
701 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 4
702 ELECTROCARDIOGRAM T WAVE PEAKED 4
703 EXPIRED DEVICE USED 4
704 EXPIRED PRODUCT ADMINISTERED 4
705 EXPOSURE DURING PREGNANCY 4
706 EXPOSURE VIA SKIN CONTACT 4
707 FIBROMYALGIA 4
708 FOETAL EXPOSURE DURING PREGNANCY 4
709 FOOT DEFORMITY 4
710 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4
711 GASTRIC DISORDER 4
712 GASTRITIS 4
713 GOUT 4
714 GROWTH RETARDATION 4
715 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4
716 HAEMOPTYSIS 4
717 HAEMORRHOIDAL HAEMORRHAGE 4
718 HEART RATE ABNORMAL 4
719 HEPATIC FAILURE 4
720 HEPATITIS ACUTE 4
721 HEREDITARY ANGIOEDEMA 4
722 HYPERTENSIVE CRISIS 4
723 HYPORESPONSIVE TO STIMULI 4
724 ILEUS 4
725 INFUSION SITE PRURITUS 4
726 INJECTION SITE RASH 4
727 IRRITABLE BOWEL SYNDROME 4
728 JUDGEMENT IMPAIRED 4
729 KIDNEY INFECTION 4
730 LEFT VENTRICULAR DYSFUNCTION 4
731 LIBIDO DECREASED 4
732 LOSS OF LIBIDO 4
733 MAST CELL ACTIVATION SYNDROME 4
734 MATERNAL EXPOSURE DURING PREGNANCY 4
735 MENSTRUATION IRREGULAR 4
736 MUSCLE TIGHTNESS 4
737 MUSCULOSKELETAL DISCOMFORT 4
738 OVERWEIGHT 4
739 PARAESTHESIA ORAL 4
740 PATIENT UNCOOPERATIVE 4
741 PERIODIC LIMB MOVEMENT DISORDER 4
742 PERSONALITY DISORDER 4
743 PHOTOSENSITIVITY REACTION 4
744 PNEUMONIA ASPIRATION 4
745 PNEUMOTHORAX 4
746 POISONING 4
747 POISONING DELIBERATE 4
748 PRODUCT COMMUNICATION ISSUE 4
749 PRODUCT CONTAINER ISSUE 4
750 PRODUCT DISPENSING ISSUE 4
751 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4
752 PRODUCT PACKAGING QUANTITY ISSUE 4
753 PRODUCT PREPARATION ERROR 4
754 PSYCHIATRIC SYMPTOM 4
755 PULMONARY HAEMORRHAGE 4
756 RASH PAPULAR 4
757 RENAL CELL CARCINOMA 4
758 RENAL TUBULAR NECROSIS 4
759 RESPIRATORY DISORDER 4
760 RESPIRATORY DISTRESS 4
761 RESPIRATORY RATE DECREASED 4
762 RESPIRATORY TRACT INFECTION 4
763 SCOLIOSIS 4
764 SICKLE CELL ANAEMIA WITH CRISIS 4
765 SINUS DISORDER 4
766 SKIN IRRITATION 4
767 SKIN LACERATION 4
768 SKIN ULCER 4
769 SNEEZING 4
770 SOCIAL PROBLEM 4
771 SPINAL OPERATION 4
772 STAPHYLOCOCCAL BACTERAEMIA 4
773 TEARFULNESS 4
774 THERAPEUTIC PRODUCT EFFECT VARIABLE 4
775 THROMBOSIS 4
776 VENTRICULAR DYSKINESIA 4
777 WEIGHT FLUCTUATION 4
778 WITHDRAWAL HYPERTENSION 4
779 WRONG DOSE 4
780 ABNORMAL UTERINE BLEEDING 3
781 ADHESIVE TAPE USE 3
782 AGORAPHOBIA 3
783 ALLERGY TO PLANTS 3
784 ANKLE FRACTURE 3
785 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 3
786 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3
787 AUTISM 3
788 AUTOIMMUNE THYROIDITIS 3
789 BENIGN PROSTATIC HYPERPLASIA 3
790 BEZOAR 3
791 BLOOD ALBUMIN DECREASED 3
792 BLOOD CREATININE DECREASED 3
793 BLOOD PRESSURE ABNORMAL 3
794 BLOOD PROLACTIN DECREASED 3
795 BLOOD TESTOSTERONE DECREASED 3
796 BLOOD THYROID STIMULATING HORMONE ABNORMAL 3
797 BLOOD THYROID STIMULATING HORMONE INCREASED 3
798 BONE DISORDER 3
799 CATHETER SITE BRUISE 3
800 CATHETER SITE DISCOLOURATION 3
801 CATHETER SITE HAEMORRHAGE 3
802 CEREBRAL HAEMORRHAGE 3
803 CEREBRAL INFARCTION 3
804 CHAPPED LIPS 3
805 CHORIORETINAL DISORDER 3
806 CHROMATURIA 3
807 CLONIC CONVULSION 3
808 COLITIS ULCERATIVE 3
809 COMPLICATION OF DEVICE INSERTION 3
810 COMPLICATION OF DEVICE REMOVAL 3
811 CONJUNCTIVITIS 3
812 CONTRAINDICATED PRODUCT PRESCRIBED 3
813 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3
814 DECUBITUS ULCER 3
815 DEMENTIA 3
816 DEVICE EXPULSION 3
817 DEVICE MATERIAL ISSUE 3
818 DEVICE OCCLUSION 3
819 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3
820 DRUG MONITORING PROCEDURE NOT PERFORMED 3
821 DRUG SCREEN FALSE POSITIVE 3
822 DRUG SCREEN POSITIVE 3
823 DRUG WITHDRAWAL CONVULSIONS 3
824 DRY THROAT 3
825 DYSGRAPHIA 3
826 ELECTRIC SHOCK SENSATION 3
827 ELECTROCARDIOGRAM QT SHORTENED 3
828 ELECTROENCEPHALOGRAM ABNORMAL 3
829 ELECTROLYTE IMBALANCE 3
830 ENDOCARDITIS 3
831 ENERGY INCREASED 3
832 EOSINOPHIL COUNT ABNORMAL 3
833 ERECTILE DYSFUNCTION 3
834 EXERCISE TOLERANCE DECREASED 3
835 EXOSTOSIS 3
836 EXPIRED DRUG ADMINISTERED 3
837 EXPOSURE VIA INGESTION 3
838 EYE MOVEMENT DISORDER 3
839 FEBRILE NEUTROPENIA 3
840 FEELING DRUNK 3
841 FLANK PAIN 3
842 FLUID INTAKE REDUCED 3
843 FOAMING AT MOUTH 3
844 FOOD ALLERGY 3
845 FOOT FRACTURE 3
846 FULL BLOOD COUNT DECREASED 3
847 GASTRIC ULCER 3
848 GASTROINTESTINAL PAIN 3
849 GLOSSODYNIA 3
850 GLYCOGEN STORAGE DISEASE TYPE VIII 3
851 GRAND MAL CONVULSION 3
852 HAEMATEMESIS 3
853 HAEMATOCRIT DECREASED 3
854 HAEMATOLOGICAL INFECTION 3
855 HALLUCINATIONS, MIXED 3
856 HEAD DISCOMFORT 3
857 HIRSUTISM 3
858 HYPERLIPIDAEMIA 3
859 HYPERPARATHYROIDISM SECONDARY 3
860 HYPERTHERMIA 3
861 HYPERTRICHOSIS 3
862 HYPERVENTILATION 3
863 HYPOACUSIS 3
864 HYPOKALAEMIA 3
865 HYPOTHYROIDISM 3
866 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 3
867 INCREASED TENDENCY TO BRUISE 3
868 INFUSION SITE BRUISING 3
869 INFUSION SITE SWELLING 3
870 INJECTION SITE INDURATION 3
871 INJECTION SITE VESICLES 3
872 INTERCEPTED PRODUCT DISPENSING ERROR 3
873 INTERMITTENT EXPLOSIVE DISORDER 3
874 INTERVERTEBRAL DISC DEGENERATION 3
875 INTERVERTEBRAL DISC PROTRUSION 3
876 INTRACRANIAL PRESSURE INCREASED 3
877 JOINT DISLOCATION 3
878 JOINT STIFFNESS 3
879 LEARNING DISABILITY 3
880 LIGAMENT SPRAIN 3
881 LIVER DISORDER 3
882 LOW DENSITY LIPOPROTEIN INCREASED 3
883 LYMPHADENOPATHY 3
884 MALABSORPTION 3
885 MALNUTRITION 3
886 MENINGITIS 3
887 METABOLIC DISORDER 3
888 MICROCYTIC ANAEMIA 3
889 MOANING 3
890 MULTIPLE INJURIES 3
891 MUSCULOSKELETAL PAIN 3
892 MYOCLONUS 3
893 NEAR DEATH EXPERIENCE 3
894 NEOPLASM MALIGNANT 3
895 NEPHROTIC SYNDROME 3
896 NEUROMYOPATHY 3
897 NONSPECIFIC REACTION 3
898 NYSTAGMUS 3
899 OCULAR DISCOMFORT 3
900 ORAL HERPES 3
901 OROPHARYNGEAL DISCOMFORT 3
902 OSTEOPENIA 3
903 OSTEOPOROSIS 3
904 OTORRHOEA 3
905 OXYGEN SATURATION ABNORMAL 3
906 PANCREATITIS 3
907 PANCREATITIS ACUTE 3
908 PARADOXICAL DRUG REACTION 3
909 PERIPHERAL COLDNESS 3
910 PERSONALITY CHANGE 3
911 PHYSICAL DISABILITY 3
912 PITUITARY TUMOUR 3
913 PNEUMONIA BACTERIAL 3
914 POLYCYSTIC OVARIAN SYNDROME 3
915 POLYDIPSIA 3
916 POST PROCEDURAL COMPLICATION 3
917 POSTURING 3
918 PRESSURE OF SPEECH 3
919 PRODUCT CONTAINER SEAL ISSUE 3
920 PRODUCT CONTAMINATION 3
921 PRODUCT NAME CONFUSION 3
922 PRODUCT PACKAGING ISSUE 3
923 PROPOFOL INFUSION SYNDROME 3
924 PROTEIN URINE PRESENT 3
925 PROTEINURIA 3
926 PROTRUSION TONGUE 3
927 PRURITUS GENERALISED 3
928 PSEUDOMONAS INFECTION 3
929 PSORIATIC ARTHROPATHY 3
930 PULMONARY CONGESTION 3
931 PULMONARY FUNCTION TEST DECREASED 3
932 PULSE ABSENT 3
933 PYELOCALIECTASIS 3
934 RAYNAUD^S PHENOMENON 3
935 RENAL CYST 3
936 RESPIRATORY RATE INCREASED 3
937 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3
938 RHEUMATOID ARTHRITIS 3
939 SCAB 3
940 SELF INJURIOUS BEHAVIOUR 3
941 SENSITIVE SKIN 3
942 SINUS CONGESTION 3
943 SINUS OPERATION 3
944 SKIN DISORDER 3
945 SKIN WEEPING 3
946 SLEEP TALKING 3
947 STEREOTYPY 3
948 SWEAT TEST ABNORMAL 3
949 SWELLING OF EYELID 3
950 SYMPTOM MASKED 3
951 TENDON DISORDER 3
952 TENDON RUPTURE 3
953 THERAPEUTIC PRODUCT EFFECT DELAYED 3
954 TONGUE DISCOMFORT 3
955 TOOTH FRACTURE 3
956 TUBULOINTERSTITIAL NEPHRITIS 3
957 TYPE 1 DIABETES MELLITUS 3
958 URINARY TRACT OBSTRUCTION 3
959 URINE PROTEIN/CREATININE RATIO ABNORMAL 3
960 VAGINAL HAEMORRHAGE 3
961 VITAMIN D DECREASED 3
962 ABDOMINAL PAIN LOWER 2
963 ACANTHOSIS NIGRICANS 2
964 ACIDOSIS 2
965 ACUTE MYELOID LEUKAEMIA 2
966 ADJUSTMENT DISORDER 2
967 ADRENAL INSUFFICIENCY 2
968 ADULTERATED PRODUCT 2
969 ALLERGIC REACTION TO EXCIPIENT 2
970 AMINO ACID LEVEL INCREASED 2
971 AMYLASE INCREASED 2
972 ANION GAP ABNORMAL 2
973 ANKYLOSING SPONDYLITIS 2
974 ANXIETY DISORDER 2
975 AORTIC VALVE INCOMPETENCE 2
976 ASCITES 2
977 ATELECTASIS 2
978 BACTERIAL INFECTION 2
979 BLADDER SPASM 2
980 BLOOD CREATINE INCREASED 2
981 BLOOD DISORDER 2
982 BLOOD IRON DECREASED 2
983 BLOOD LOSS ANAEMIA 2
984 BLOOD PRESSURE INADEQUATELY CONTROLLED 2
985 BLOOD PRESSURE SYSTOLIC DECREASED 2
986 BLOOD PRESSURE SYSTOLIC INCREASED 2
987 BLOOD THYROID STIMULATING HORMONE DECREASED 2
988 BLUNTED AFFECT 2
989 BODY HEIGHT DECREASED 2
990 BRAIN HERNIATION 2
991 BREAST CANCER 2
992 BREAST DISORDER 2
993 BRIEF RESOLVED UNEXPLAINED EVENT 2
994 BRONCHIOLITIS 2
995 BRONCHOSPASM 2
996 CANDIDA INFECTION 2
997 CARDIAC FLUTTER 2
998 CARDIOVASCULAR DISORDER 2
999 CATHETER SITE SWELLING 2